Newsroom

Latest Medical/Pharmaceuticals News

News releases related to the Medical/Pharmaceuticals industry.

• 

  Leviathan Cannabis Group Inc. Appoints Martin J. Doane as Interim CFO

  Toronto, Ontario--(Newsfile Corp. - February 22, 2019) - Leviathan Cannabis Group Inc. (CSE: EPIC) (the "Company" or "Leviathan") announces the departure of Cheryl Sarnavka as Chief Financial Officer, effective February 21, 2019.The Board of Directors (the "Board") has appointed Martin J. Doane as Interim Chief Financial Officer. Mr. Doane currently ...
  Medical/Pharmaceuticals, Cannabis
  2019-02-22 5:05 PM ET | Leviathan Cannabis Group Inc.
• 

  TransCanna Signs LOI To Lease Manufacturing and Logistics Facility in Southern California

  Vancouver, British Columbia--(Newsfile Corp. - February 22, 2019) - TransCanna Holdings Inc. (CSE:TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce the execution of an LOI to lease a new 15,000 square foot facility currently under construction with a completion date of April 30th in Adelanto, CA.  This ...
  Medical/Pharmaceuticals, Cannabis
  2019-02-22 3:20 AM ET | TransCanna Holdings Inc.
• 

  Canbiola Deploys Initial 100 sam(R) Units and Readies Next 100 sam(R) Units

  Hicksville, New York--(Newsfile Corp. - February 21, 2019) -  Canbiola, Inc. (OTCQB: CANB) ("Canbiola" or the "Company"), a developer, manufacturer and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, vapes, isolate, gel caps and concentrate, announced today that its initial 100 Sustained Acoustic ...
  Medical/Pharmaceuticals, Cannabis
  2019-02-21 10:00 AM ET | Canbiola Inc.
• 

  TransCanna Announces $10.0 M Brokered Private Placement

  Vancouver, British Columbia--(Newsfile Corp. - February 20, 2019) - TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) ("TransCanna" or the "Company") is pleased to announce that it has appointed Haywood Securities Inc. ("Haywood") to act as lead agent on behalf of a syndicate of agents to be formed, including Gravitas ...
  Medical/Pharmaceuticals, Cannabis
  2019-02-20 5:56 PM ET | TransCanna Holdings Inc.
• 

  Biocure Technology Corp Announces a MOU with the Government of Uzbekistan and Gold-Dream LLC to Build a Manufacturing Plant to Produce Biosimilars

  Vancouver, British Columbia--(Newsfile Corp. - February 19, 2019) - Biocure Technology Corp. (CSE: CURE) (OTCQB: BICTF) ("CURE" or the "Company") BiocurePharm, Korea ("BPK"), a wholly owned subsidiary of Biocure Technology Inc. ("CURE") has entered into a Memorandum of Understanding with the Agency of Development of the Pharmaceutical Industry under the Ministry ...
  Biotechnology, Medical/Pharmaceuticals
  2019-02-19 9:00 AM ET | Biocure Technology Inc.
• 

  iCo Therapeutics Inc. Announces Upsizing of Non-Brokered Private Placement to $1,250,000 CDN

  Vancouver, British Columbia--(Newsfile Corp. - February 19, 2019) -  iCo Therapeutics Inc. (TSXV: ICO) (OTCQB: ICOTF) ("iCo" or "the Company") announces an upsizing of a previously announced Non-brokered private placement to $1,250,000 CDN.Each Unit issued pursuant to the Private Placement consists of one common share in the capital of the ...
  Medical/Pharmaceuticals
  2019-02-19 6:00 AM ET | iCo Therapeutics Inc.
• 

  iCo Therapeutics Inc. Announces Notice of Termination of Sub License for Bertilimumab (iCo-008)

  Vancouver, British Columbia--(Newsfile Corp. - February 19, 2019) -  iCo Therapeutics Inc. (TSXV: ICO) (OTCQB: ICOTF) ("iCo" or "the Company") announces that on Friday February 15, 2019 the Company delivered written notice terminating, with immediate effect, its product sublicense agreement with Immune Pharmaceuticals (IMNP: OTCQB), related to iCo-008 (Bertilimumab). ...
  Medical/Pharmaceuticals
  2019-02-19 5:45 AM ET | iCo Therapeutics Inc.
• 

  TransCanna Announces Corporate Update Conference Call

  Vancouver, British Columbia--(Newsfile Corp. - February 15, 2019) - TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) ("TransCanna" or the "Company") intends to host a corporate update conference call, after the close of the market at approximately 1:15pm (pst) on Tuesday February 19th, 2019. The agenda for the call is to ...
  Medical/Pharmaceuticals, Cannabis
  2019-02-15 5:07 PM ET | TransCanna Holdings Inc.
• 

  The Green Scene Podcast: Reporting On TransCanna's Major Acquisition Update

  Vancouver, British Columbia--(Newsfile Corp. - February 15, 2019) - On this episode of The Green Scene Podcast we provide our listeners with an exclusive update from Jim Pakulis, CEO of TransCanna Holdings (CSE: TCAN) (FSE: TH8).Our discussion today focuses on the acquisition of arguably the largest cannabis focused facility ...
  Medical/Pharmaceuticals, Cannabis
  2019-02-15 4:00 AM ET | TransCanna Holdings Inc.
• 

  Tidal to Continue as American MSO Following Proposed Acquisition of Red, White and Bloom

  Toronto, Ontario--(Newsfile Corp. - February 14, 2019) - Tidal Royalty Inc. (CSE: RLTY.U) ("Tidal" or the "Company"), a leading provider of royalty financing to licensed U.S. cannabis operators, is pleased to announce that it has entered into a binding letter of intent (the "LOI") with MichiCann Medical Inc. (operating as ...
  Medical/Pharmaceuticals, Cannabis
  2019-02-14 10:17 AM ET | Tidal Royalty Corp.
• 

  Biocure Technology Inc. Announces Private Placement

  Vancouver, British Columbia--(Newsfile Corp. - February 14, 2019) -  Biocure Technology Corp. (CSE: CURE) (OTCQB: BICTF) ("CURE" or the "Company") is pleased to announce that it has arranged a non-brokered private placement of 6,976,745 million units at 43 cents per unit for gross proceeds of $3 Million or more, depending on investor ...
  Biotechnology, Medical/Pharmaceuticals
  2019-02-14 9:00 AM ET | Biocure Technology Inc.
• 

  TransCanna Announces the Completion of 420 Global

  Vancouver, British Columbia--(Newsfile Corp. - February 14, 2019) -  TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) ("TransCanna" or the "Company") is pleased to announce that it has completed phase I of its proprietary software platform called "420 Global".The state-of-the-art proprietary software is designed to create a Business Intelligence backend that ...
  Medical/Pharmaceuticals, Cannabis
  2019-02-14 3:15 AM ET | TransCanna Holdings Inc.
• 

  PreveCeutical Announces Appointment of Dr. Makarand Jawadekar as President

  Vancouver, British Columbia--(Newsfile Corp. - February 13, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") is pleased to announce the appointment of Dr. Makarand (Mak) Jawadekar as the President of the Company, effective immediately. Dr. Jawadekar will also continue as the Chief ...
  Biotechnology, Medical/Pharmaceuticals
  2019-02-13 8:30 AM ET | PreveCeutical Medical Inc.
• 

  PreveCeutical Announces Closing of Non-Brokered Private Placement

  Vancouver, British Columbia--(Newsfile Corp. - February 12, 2019) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces the closing of a non-brokered private placement financing (the "Financing"). A total of 6,100,000 units (the "Units") were issued under the Financing at a price of $0.05 ...
  Biotechnology, Medical/Pharmaceuticals
  2019-02-12 8:30 AM ET | PreveCeutical Medical Inc.
• 

  Cell MedX Corp. Provides an Update on Progress Toward US Premarket Clearance and Clarifies its eBalance Certification

  Carson City, Nevada--(Newsfile Corp. - February 12, 2019) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), an early development stage biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness is pleased to announce significant progress toward obtaining premarket ...
  Medical/Pharmaceuticals
  2019-02-12 8:00 AM ET | Cell MedX Corp
• 

  iCo Therapeutics Inc. Announces the Issuance of 4,000,000 Units Pursuant to its C$750,000 Non-Brokered Private Placement

  Vancouver, British Columbia--(Newsfile Corp. - February 11, 2019) - iCo Therapeutics Inc. (TSXV: ICO) (OTCQB: ICOTF) ("iCo" or "the Company") is pleased to announce that it has issued a total of 4,000,000 units (the "Units") to a Canadian institutional investor pursuant to its previously announced non-brokered private placement (the "Private ...
  Medical/Pharmaceuticals
  2019-02-11 7:19 PM ET | iCo Therapeutics Inc.
• 

  Acquisition Of GoodFellas Will Include Proprietary Brand called Simple, includes the Simple Kit(TM)

  Vancouver, British Columbia--(Newsfile Corp. - February 8, 2019) - TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) ("TransCanna" or the "Company") is pleased to announce that subject to completing of the acquisition of Goodfellas Group, LLC ("Goodfellas"), the company will, in addition to the branding and marketing business of Goodfellas, acquire ...
  Medical/Pharmaceuticals, Cannabis
  2019-02-08 3:15 AM ET | TransCanna Holdings Inc.
• 

  Biocure Shares DTC Eligible

  Vancouver, British Columbia--(Newsfile Corp. - February 7, 2019) - Biocure Technology Corp. (CSE: CURE) (OTCQB: BICTF) ("CURE" or the "Company") is pleased to announce that its OTCQB-listed common shares are now eligible for electronic clearing and settlement through the Depository Trust Company ("DTC") in the United States.DTC is a ...
  Biotechnology, Medical/Pharmaceuticals
  2019-02-07 9:00 AM ET | Biocure Technology Inc.
• 

  Leviathan Cannabis - MariGrow Inc. Letter of Intent Cancelled

  Toronto, Ontario--(Newsfile Corp. - February 6, 2019) - Leviathan Cannabis Group Inc. (CSE: EPIC) (the "Company" or "Leviathan") reports that the Letter of Intent to acquire all issued and outstanding shares of MariGrow Inc., which was announced on January 17, 2019, has been terminated. Leviathan continues to explore growth ...
  Medical/Pharmaceuticals, Cannabis
  2019-02-06 5:15 PM ET | Leviathan Cannabis Group Inc.
• 

  Canon to Showcase CVR Medical's Carotid Stenotic Scan (CSS) at Medical Design & Manufacturing West (MD&M)

  Denver, North Carolina--(Newsfile Corp. - February 5, 2019) - CVR Medical Corp. (TSXV: CVM) (OTCQB: CRRVF) ("CVR"), a Canadian listed and US based healthcare company in the medical device sector announces it will have its upcoming "Carotid Stenotic Scan (CSS)" device showcased by its manufacturing and strategic partner ...
  Technology, Medical/Pharmaceuticals
  2019-02-05 12:00 PM ET | CVR Medical Corp.
• 

  Leviathan Cannabis - Management Cease Trade Order Lifted

  Toronto, Ontario--(Newsfile Corp. - February 4, 2019) - Leviathan Cannabis Group Inc. (CSE: EPIC) (the "Company" or "Leviathan") announces that the Management Cease Trade Order ("MCTO") imposed by the Ontario Securities Commission ("OSC") on January 7, 2019 has been revoked. With the revocation of the MCTO, directors, officers and ...
  Medical/Pharmaceuticals, Cannabis
  2019-02-04 6:00 PM ET | Leviathan Cannabis Group Inc.
• 

  TransCanna Enters Into Option To Acquire 196,000 Square Foot, Fully Enclosed Cannabis Facility on 6.5 Acres of Land

  Vancouver, British Columbia--(Newsfile Corp. - February 4, 2019) - TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) ("TransCanna" or the "Company") is pleased to announce that on February 1st the Company accepted an assignment of a real estate option agreement ("Option Agreement") from its CEO, Jim Pakulis, to acquire a ...
  Medical/Pharmaceuticals, Cannabis
  2019-02-04 7:00 AM ET | TransCanna Holdings Inc.
• 

  iCo Therapeutics Inc. Announces Non-Brokered Private Placement to Raise C$750,000

  Vancouver, British Columbia--(Newsfile Corp. - January 31, 2019) - iCo Therapeutics Inc. (TSXV: ICO) (OTCQX: ICOTF) ("iCo" or "the Company") is pleased to announce that it has issued a total of 3,000,000 units (the "Units") pursuant to the first tranche of a non-brokered private placement (the "Private Placement"). ...
  Medical/Pharmaceuticals
  2019-01-31 8:06 PM ET | iCo Therapeutics Inc.
• 

  Leviathan Cannabis - Announces Expected Release Date for Interim Financial Statements for the Quarter Ending November 30, 2018

  Toronto, Ontario--(Newsfile Corp. - January 29, 2019) - Leviathan Cannabis Group Inc. (CSE: EPIC) (the "Company" or "Leviathan") previously announced on January 28, 2019 that it expects to file its audited annual financial statements for the year ended August 31, 2018 on or before January 31, 2019. Once that filing ...
  Medical/Pharmaceuticals, Cannabis
  2019-01-29 5:35 PM ET | Leviathan Cannabis Group Inc.
• 

  TransCanna Signs LOI To Acquire Goodfellas Group, LLC

  Vancouver, British Columbia--(Newsfile Corp. - January 29, 2019) -  TransCanna Holdings Inc. (CSE: TCAN) (XETR: TH8) ("TransCanna" or the "Company") is pleased to announce that it has signed a non-binding Letter of Intent to acquire Goodfellas Group, LLC, ("Goodfellas") a full service advertising and marketing agency for the cannabis and ...
  Medical/Pharmaceuticals, Cannabis
  2019-01-29 9:30 AM ET | TransCanna Holdings Inc.